Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter

被引:66
作者
Gabriel, EM
Bergert, ER
Grant, CS
van Heerden, JA
Thompson, GB
Morris, JC [1 ]
机构
[1] Mayo Clin & Mayo Grad Sch Med, Div Endocrinol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Grad Sch Med, Dept Surg, Rochester, MN 55905 USA
关键词
D O I
10.1210/jc.84.9.3328
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Toxic multinodular goiter (TMNG) represents a frequent cause of endogenous hyperthyroidism, affecting 5-15% of such patients (with higher frequencies reported in iodine-deficient areas of the world). Although mutations of human TSH receptor (hTSHR) have been described in autonomously functioning thyroid nodules (AFTN) the role of such mutations in the pathogenesis of TMNG remains unclear. To search for alterations of hTSHR in AFTN and TMNG, we performed bidirectional, dye primer automated fluorescent DNA sequencing of the entire transmembrane domain and cytoplasmic tail of hTSHR (TMD+CT-hTSHR) using DNA extracted from nodular regions of 24 patients with TMNG and 7 patients with AFTN. Eight of the 24 patients (33.3%) showed heterozygote polymorphism of codon 727 on the cytoplasmic tail of hTSHR with an amino acid substitution of aspartic acid to glutamic acid. Three of 24 (12.5%) patients with TMNG were found to carry a heterozygote mutation of codon 703, resulting in substitution of alanine with glycine. One patient had multiple heterozygote mutations including I606M (IIe to Met), A703G (Ala to Gly), Q720E (Gln to Glu), and D727E (Asp to Glu). Two patients exhibited silent polymorphism of codons 460 and 618. We found no mutation of the TMD+CT-hTSHR in 7 patients with AFTN, except for a silent polymorphism of codon 460 in 1. DNA fingerprinting of codon 727 using restriction enzyme NlaIII and genomic DNA confirmed the sequencing results in all cases, indicating that the sequence alterations were not somatic in nature. This technique was also used to examine peripheral blood genomic DNA from 52 normal individuals and 49 patients with Graves' disease; 33.3% of TMNG (P = 0.019 vs. normal subjects), 16.3% of Graves' disease patients (P = 0.10 vs, normal subjects), and 9.6% of normal individuals were heterozygous for the D727E polymorphism. Expression of the D727E hTSHR variant in eukaryotic cells (COS-7) resulted in an exaggerated cAMP response to TSH stimulation compared to that of the wild-type hTSHR. These findings indicate that a germline polymorphism of codon D727E of hTSHR is associated with TMNG, suggesting that its presence is an important predisposing genetic factor in the pathogenesis of TMNG.
引用
收藏
页码:3328 / 3335
页数:8
相关论文
共 49 条
[21]   THE EFFECTS OF SYNTHETIC ALPHA-SUBUNIT PEPTIDES ON THYROID-STIMULATING IMMUNOGLOBULIN ACTIVITY [J].
MORRIS, JC ;
JIANG, NS ;
HAY, ID ;
CHARLESWORTH, MC ;
MCCORMICK, DJ ;
RYAN, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (04) :707-712
[22]   THE EFFECTS OF SYNTHETIC ALPHA-SUBUNIT PEPTIDES ON THYROTROPIN INTERACTION WITH ITS RECEPTOR [J].
MORRIS, JC ;
JIANG, NS ;
CHARLESWORTH, MC ;
MCCORMICK, DJ ;
RYAN, RJ .
ENDOCRINOLOGY, 1988, 123 (01) :456-462
[23]   SOMATIC MUTATIONS CAUSING CONSTITUTIVE ACTIVITY OF THE THYROTROPIN RECEPTOR ARE THE MAJOR CAUSE OF HYPERFUNCTIONING THYROID ADENOMAS - IDENTIFICATION OF ADDITIONAL MUTATIONS ACTIVATING BOTH THE CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE AND INOSITOL PHOSPHATE-CA2+ CASCADES [J].
PARMA, J ;
VANSANDE, J ;
SWILLENS, S ;
TONACCHERA, M ;
DUMONT, J ;
VASSART, G .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (06) :725-733
[24]   SOMATIC MUTATIONS IN THE THYROTROPIN RECEPTOR GENE CAUSE HYPERFUNCTIONING THYROID ADENOMAS [J].
PARMA, J ;
DUPREZ, L ;
VANSANDE, J ;
COCHAUX, P ;
GERVY, C ;
MOCKEL, J ;
DUMONT, J ;
VASSART, G .
NATURE, 1993, 365 (6447) :649-651
[25]   CURRENT EVIDENCE FOR AND AGAINST THE TSH RECEPTOR BEING THE COMMON ANTIGEN IN GRAVES-DISEASE AND THYROID-ASSOCIATED OPHTHALMOPATHY [J].
PASCHKE, R ;
VASSART, G ;
LUDGATE, M .
CLINICAL ENDOCRINOLOGY, 1995, 42 (06) :565-569
[26]   PRESENCE OF NONFUNCTIONAL THYROTROPIN RECEPTOR VARIANT TRANSCRIPTS IN RETROOCULAR AND OTHER TISSUES [J].
PASCHKE, R ;
METCALFE, A ;
ALCALDE, L ;
VASSART, G ;
WEETMAN, A ;
LUDGATE, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (05) :1234-1238
[27]   IDENTIFICATION AND FUNCTIONAL-CHARACTERIZATION OF 2 NEW SOMATIC MUTATIONS CAUSING CONSTITUTIVE ACTIVATION OF THE THYROTROPIN RECEPTOR IN HYPERFUNCTIONING AUTONOMOUS ADENOMAS OF THE THYROID [J].
PASCHKE, R ;
TONACCHERA, M ;
VANSANDE, J ;
PARMA, J ;
VASSART, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1785-1789
[28]   USE OF DNA POLYMORPHISMS FOR GENETIC-ANALYSIS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
PERMUTT, MA .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1991, 5 (03) :495-526
[29]  
POLAND GA, 1995, FASEB J, V9, pA240
[30]   Genetic polymorphisms in human drug-metabolizing enzymes: Potential uses of reverse genetics to identify genes of toxicological relevance [J].
Puga, A ;
Nebert, DW ;
McKinnon, RA ;
Menon, AG .
CRITICAL REVIEWS IN TOXICOLOGY, 1997, 27 (02) :199-222